| Hy-vee Pharmacy (1040) | |
| 9409 Zane Ave N, Brooklyn Park, Minnesota 55443 | |
| (763) 488-4502 |
| Name | Hy-vee Pharmacy (1040) |
|---|---|
| Organization Name | Hy Vee Inc |
| Location | 9409 Zane Ave N, Brooklyn Park, Minnesota 55443 |
| Type | Community/Retail Pharmacy |
| Phone | (763) 488-4502 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Black men and women have higher incidences than whites of developing advanced heart failure following a heart attack.
Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.
The blink reflex has been shown to be sensitive to a number of neurological insults, including traumatic brain injury, Parkinson's disease and Huntington's disease, suggesting that it could be a useful tool for neurological assessment.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 7 days ago
| NPI Number | 1144679010 |
| Organization Name | HY-VEE INC |
| Doing Business As | HY-VEE PHARMACY (1040) |
| Type | Community/Retail Pharmacy |
| Address | 9409 Zane Ave N, Brooklyn Park, MN 55443 |
| Phone Number | 763-488-4502 |
News Archive
Black men and women have higher incidences than whites of developing advanced heart failure following a heart attack.
Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.
The blink reflex has been shown to be sensitive to a number of neurological insults, including traumatic brain injury, Parkinson's disease and Huntington's disease, suggesting that it could be a useful tool for neurological assessment.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 7 days ago
News Archive
Black men and women have higher incidences than whites of developing advanced heart failure following a heart attack.
Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.
The blink reflex has been shown to be sensitive to a number of neurological insults, including traumatic brain injury, Parkinson's disease and Huntington's disease, suggesting that it could be a useful tool for neurological assessment.
EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that its EyeOP1 device is to be installed in a number of hospitals in France, namely Lille University Hospital, Grenoble University Hospital and the Quinze-Vingts and Saint-Joseph hospitals in Paris. The first use of this device for the routine treatment of glaucoma patients is slated from July onwards.
› Verified 7 days ago
Cvs Pharmacy #16213 Type: Community/Retail Pharmacy Location: 7535 W Broadway Ave, Brooklyn Park, Minnesota 55428 Phone: (763) 425-5300 | |
Cvs Pharmacy #11070 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4400 Oak Grove Parkway, Brooklyn Park, Minnesota 55443 Phone: (763) 315-1935 | |
Walmart Pharmacy 10-1864 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8000 Lakeland Ave N, Brooklyn Park, Minnesota 55445 Phone: (763) 424-7077 | |
Walgreens #2316 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2024 85th Ave N, Brooklyn Park, Minnesota 55444 Phone: (763) 424-9243 | |
Hy-vee Pharmacy (1040) Type: Community/Retail Pharmacy Location: 9409 Zane Ave N, Brooklyn Park, Minnesota 55443 Phone: (763) 488-4502 |